Evidence map›Paper›PMID 40463086›Full record

ArticlebioRxiv : the preprint server for biology2025

Evaluation of epistasis detection methods for quantitative phenotypes.

Stanislav Listopad, Gauri Renjith, Qian Peng

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Stanislav ListopadDepartment of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-7983-7879
Gauri RenjithDepartment of Computer Science and Engineering, University of California, San Diego, San Diego, CA 92093, USA.
Qian PengDepartment of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037, USA.

Funding

ABCD-USA Consortium: Coordinating CenterU24DA041147 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SANDRA A BROWN, TERRY L. JERNIGAN · 2015 to 2026
$54.7M
ABCD-USA Consortium: Data Analysis, Informatics and Resource CenterU24DA041123 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE · 2015 to 2026
$51.5M
Adolescent Substance Use Initiation: Disentangling neurocognitive risks from consequences using longitudinal and genetically-informed methodsU01DA041120 · NIDA · UNIVERSITY OF MINNESOTA · PI Monica Luciana, Sylia Wilson · 2015 to 2026
$34.5M
ABCD-USA Consortium: Research ProjectU01DA041089 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joanna Jacobus, Susan F. Tapert · 2015 to 2026
$31.7M
Prospective Research Studies of Maturation (PRISM)- Research ProjectU01DA041134 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ERIN MCGLADE, PERRY FRANKLIN RENSHAW · 2015 to 2026
$29.2M
ABCD-USA CONSORTIUM: RESEARCH PROJECTU01DA041048 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI Megan Marie Herting, ELIZABETH R SOWELL · 2015 to 2026
$28.7M
ABCD-USA Consortium: Research ProjectU01DA041106 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mary M Heitzeg, Chandra Sekhar Sripada · 2015 to 2026
$24.9M
FIU-ABCD: Pathways and Mechanisms to Addiction in the Latino Youth of South FloridaU01DA041156 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI Raul Gonzalez, Angela R Laird · 2015 to 2026
$22.8M
ABCD-USA Consortium: Research ProjectU01DA041148 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Damien A Fair, Rebekah S Huber · 2015 to 2026
$22.3M
ABCD-USA: NYC Research ProjectU01DA041174 · NIDA · YALE UNIVERSITY · PI Arielle Ryan Baskin-Sommers, Betty J Casey · 2015 to 2026
$19.7M
Adolescent Brain Cognitive Development (ABCD) Prospective Research in Studies of Maturation (PRISM) ConsortiumU01DA041117 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDA CHANG, THOMAS M ERNST · 2015 to 2026
$19.5M
15/21 ABCD-USA Consortium: Research Project Site at LIBRU01DA050989 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI ROBIN L AUPPERLE, MARTIN P. PAULUS · 2020 to 2026
$14.7M
NIAAA NIH HHS T32 AA007456NIDA NIH HHS DP1 DA054373NIDA NIH HHS U01 DA041022NIDA NIH HHS U01 DA041025NIDA NIH HHS U01 DA041028NIDA NIH HHS U01 DA041048NIDA NIH HHS U01 DA041089NIDA NIH HHS U01 DA041093NIDA NIH HHS U01 DA041106NIDA NIH HHS U01 DA041117NIDA NIH HHS U01 DA041120NIDA NIH HHS U01 DA041134NIDA NIH HHS U01 DA041148NIDA NIH HHS U01 DA041156NIDA NIH HHS U01 DA041174NIDA NIH HHS U01 DA050987NIDA NIH HHS U01 DA050988NIDA NIH HHS U01 DA050989NIDA NIH HHS U01 DA051016NIDA NIH HHS U01 DA051018NIDA NIH HHS U01 DA051037NIDA NIH HHS U01 DA051038NIDA NIH HHS U01 DA051039NIDA NIH HHS U24 DA041123NIDA NIH HHS U24 DA041147
6 · The paper itself

Abstract

Background: Epistasis, or genetic interaction, has been increasingly recognized for its ubiquity and for its role in susceptibility to common human diseases, such as Alzheimer's. A wide variety of epistasis detection tools are currently available with several studies comparing the performance of methods suitable for case-control data. However, there is limited understanding of how well these tools perform with quantitative phenotypes. Methods: We identified six epistasis detection methods suitable for quantitative phenotype data: EpiSNP, Matrix Epistasis, MIDESP, PLINK Epistasis, QMDR, and REMMA. To evaluate these tools, we generated simulated datasets using EpiGEN. The datasets modeled various pairwise interactions between disease-associated SNPs, including dominant, multiplicative, recessive, and XOR interactions. Additionally, we assessed the BOOST and MDR algorithms on discretized (case-control) version of the datasets. These tools were then tested on the Adolescent Brain Cognitive Development (ABCD) dataset for the externalizing behavior phenotype. Results: Each tool exhibited strong performance for certain interaction types, but weaker performance for others. MDR achieved the highest overall detection rate of 60%, while EpiSNP had the lowest overall detection rate of 7%. MDR and MIDESP performed best at detecting multiplicative interactions with detection rates of 54% and 41% respectively. Both MDR and MIDESP were also effective at detecting XOR interactions with detection rates of 84% and 50% respectively. PLINK Epistasis, Matrix Epistasis, and REMMA excelled at detecting dominant interactions, all achieving a 100% detection rate. On the other hand, EpiSNP was particularly effective at detecting recessive interactions with a detection rate of 66%. When analyzing the ABCD dataset, Plink Epistasis and Plink BOOST identified SNPs within the Conclusion: Since no single method consistently outperforms others across all types of epistasis, and given that the specific types of epistasis present in a dataset are often unknown, it may be more effective to use multiple epistasis detection algorithms in combination to obtain comprehensive results.

Indexed as

epistasisgenetic interactionquantitative phenotypesimulationsoftware benchmark

Identifiers

PMID40463086
PMCPMC12132564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.